Physician-scientists at IU School of Medicine conduct ground-breaking research to understand polycystic ovary syndrome (PCOS) and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is a hormonal disorder common among women of reproductive age. Women with PCOS may have infrequent or prolonged menstrual periods or excess male hormone (androgen) levels.

Investigator

Niharika Samala, M.D.

Assistant Professor of Medicine

Read Bio

Open Research Studies for Polycystic Ovary Syndrome

PCOS Cross-Sectional Study

Enrolling: Yes

Principle Investigator: Niharika Samala, MD

Duration: 1 visit

Patient Population: Women ages 18-45 with diagnosis of PCOS, no known diagnosis of nonalcoholic fatty liver disease (NAFLD).

Interested in this study? Please contact the clinical liver research team: iuliverr@iu.edu

Zydus - PCOS

Enrolling: Yes

Principle Investigator: Niharika Samala, MD

Duration: 28 day screening, 24 week treatment.

Patient Population: Women ages 18-45 with diagnosis of nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH) (no cirrhosis), and PCOS, ALT value > 38.

Drug(s): Saroglitizar Magnesium

Interested in this study? Please contact the clinical liver research team: iuliverr@iu.edu